DB18724InvestigationalGene Therapies
rAAV1-CB-hAAT is a recombinant adeno-associated virus alpha 1-antitrypsin vector.
- Also known as
- recombinant adeno-associated virus alpha 1-antitrypsin vector
What you can answer from here — as of April 23, 2025
Which companies are running trials of rAAV1-CB-hAAT, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account